These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32489792)

  • 1. Xanthomas Can Be Misdiagnosed and Mistreated in Homozygous Familial Hypercholesterolemia Patients: A Call for Increased Awareness Among Dermatologists and Health Care Practitioners.
    Alnouri F; Al-Allaf FA; Athar M; Abduljaleel Z; Alabdullah M; Alammari D; Alanazi M; Alkaf F; Allehyani A; Alotaiby MA; Alshehri A; Bouazzaoui A; Karrar H; Taher MM
    Glob Heart; 2020 Feb; 15(1):19. PubMed ID: 32489792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
    Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
    Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.
    Alnouri F; Athar M; Al-Allaf FA; Abduljaleel Z; Taher MM; Bouazzaoui A; Al Ammari D; Karrar H; Albabtain M
    Atherosclerosis; 2018 Oct; 277():425-433. PubMed ID: 30270081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel and Known LDLR Variants Triggering Severe Familial Hypercholesterolemia in Saudi Families.
    Alnouri F; Al-Allaf FA; Athar M; Al-Rasadi K; Alammari D; Alanazi M; Abduljaleel Z; Awan Z; Bouazzaoui A; Dairi G; Elbjeirami WM; Karra H; Kinsara AJ; Taher MM
    Curr Vasc Pharmacol; 2022; 20(4):361-369. PubMed ID: 35249492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound heterozygous LDLR variant in severely affected familial hypercholesterolemia patient.
    Al-Allaf FA; Alashwal A; Abduljaleel Z; Taher MM; Bouazzaoui A; Abalkhail H; Al-Allaf AF; Athar M
    Acta Biochim Pol; 2017; 64(1):75-79. PubMed ID: 27878139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a recurrent frameshift mutation at the LDLR exon 14 (c.2027delG, p.(G676Afs*33)) causing familial hypercholesterolemia in Saudi Arab homozygous children.
    Al-Allaf FA; Alashwal A; Abduljaleel Z; Taher MM; Siddiqui SS; Bouazzaoui A; Abalkhail H; Aun R; Al-Allaf AF; AbuMansour I; Azhar Z; Ba-Hammam FA; Khan W; Athar M
    Genomics; 2016 Jan; 107(1):24-32. PubMed ID: 26688439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia.
    Moffa S; Onori ME; De Paolis E; Ricciardi Tenore C; Perrucci A; Pontecorvi A; Giaccari A; Urbani A; Minucci A
    Mol Biol Rep; 2022 Feb; 49(2):1623-1630. PubMed ID: 34846648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe xanthomatosis in heterozygous familial hypercholesterolemia.
    Aljenedil S; Ruel I; Watters K; Genest J
    J Clin Lipidol; 2018; 12(4):872-877. PubMed ID: 29778561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
    Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
    Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genotype-phenotype analysis of a homozygous familial hypercholesterolemia pedigree].
    Wang DY; Zhang YM; Che FY; Chu JP; Zhang LY; Li H; Liu BL; Yao ZY; Zhao YW
    Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):101-106. PubMed ID: 32102145
    [No Abstract]   [Full Text] [Related]  

  • 14. [Homozygous familial hypercholesterolemia: development and a case illustration].
    Choukri M; Laaroussi N; Taheri H; Chabraoui L
    Ann Biol Clin (Paris); 2013; 71(1):99-103. PubMed ID: 23396432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
    Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
    Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia.
    Reeskamp LF; Hartgers ML; Peter J; Dallinga-Thie GM; Zuurbier L; Defesche JC; Grefhorst A; Hovingh GK
    Circ Genom Precis Med; 2018 Dec; 11(12):e002385. PubMed ID: 30562117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil.
    Silva PRS; Jannes CE; Oliveira TGM; Miname MH; Rocha VZ; Chacra AP; Gurgel MHC; Montenegro RM; Rodrigues Sobrinho CRM; Bello Moreira AS; Assad MHV; Pinto MRC; Tada MT; Santos RD; Pereira AC; Krieger JE
    Atherosclerosis; 2017 Aug; 263():257-262. PubMed ID: 28689098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
    Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
    J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cascade screening for familial hypercholesterolemia-identification of the C308Y mutation in multiple family members and relatives for the first time in mainland China.
    Jin W; Zhang Q; Wang B; Pan L; Qin H; Yang D; Zhou X; Du Y; Lin L; Kutryk MJ
    BMC Med Genet; 2019 Nov; 20(1):173. PubMed ID: 31706281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.